Bioteque Corporation (4107.TWO) Stock
Bioteque Corporation manufactures and sells medical devices in Asia, South America, North America, and internationally. The company offers angiography catheter, balloon dilation catheter, guiding sheath, guide steel wire, y-type connector, multi-pipe joint, connecting pipe, y-type connector assembly, peripheral vascular guiding catheter, coronary balloon dilation catheter, central venous catheter, microcatheter assembly, injection tube sleeve assembly for radiographic catheters, micro-puncture guide assembly, closed suction catheter, oxygen masks and tubing, anesthesia mask, sprayer and spray mask, endotracheal tube, and tracheostomy tube.
Valuation
Financials & Margins
Latest News
Valuation & Return Ratios
About Bioteque Corporation
Bioteque Corporation manufactures and sells medical devices in Asia, South America, North America, and internationally. The company offers angiography catheter, balloon dilation catheter, guiding sheath, guide steel wire, y-type connector, multi-pipe joint, connecting pipe, y-type connector assembly, peripheral vascular guiding catheter, coronary balloon dilation catheter, central venous catheter, microcatheter assembly, injection tube sleeve assembly for radiographic catheters, micro-puncture guide assembly, closed suction catheter, oxygen masks and tubing, anesthesia mask, sprayer and spray mask, endotracheal tube, and tracheostomy tube. It also provides pig tail drainage tube assembly, pig tail drainage tube, percutaneous drainage catheter accessories, insertion of drainage catheter kit, puncture and insertion system, snap lock drainage catheter set, ureteral catheter, propulsion tube, ureteral balloon dilation catheter, subcutaneous pyelostomy with ureteral catheterization, kidney transplantation ureteral catheter, tumor ureteral catheter, ureteroscopy applicable ureteral catheter, angle sleeve, and urinary tract stone removal products. In addition, it offers blood circuit tube parts, deodorizing and antibacterial spray, biliary balloon dilation catheter, nasobiliary drainage catheter, surgical drainage catheter, leg-binding urine bag, and drainage bag, as well as PVC IV infusion bags, PVC pipe bags, accessories for infusion bags, infusion extension tubing, and IV set. Bioteque Corporation was incorporated in 1991 and is headquartered in Taipei, Taiwan.
Bioteque Corporation is led by CEO Jin-Long Lin, employs 385 people, headquartered in Taipei, TW, publicly traded since 2007.
Bioteque Corporation (4107.TWO) stock trades at $108.00 with a market capitalization of $7.48B. The stock is valued at a price-to-earnings (P/E) ratio of 12.81, price-to-book of 2.12, price-to-sales of 3.37. Over the past 52 weeks the stock has ranged between $107.50 and $132.00, and currently trades 18.2% below its 52-week high. It pays a dividend yielding 5.07%.
On profitability, Bioteque Corporation generates a return on equity (ROE) of 17.29%, above the typical market range of roughly 12-15%, an operating margin of 33.35%, a net profit margin of 26.54%.
Official website: www.bioteq.com.tw/zh-tw
Bioteque Corporation (4107.TWO) — frequently asked questions
What is Bioteque Corporation (4107.TWO) stock price today?
Bioteque Corporation (4107.TWO) is currently trading at $108.00, down 0.46% today.
What is 4107.TWO P/E ratio?
Bioteque Corporation's P/E ratio is 12.81. This is below the typical market average of roughly 18-22x. A low P/E can reflect a lower valuation, slower expected growth, or both.
What is 4107.TWO return on equity (ROE)?
Bioteque Corporation's return on equity (ROE) is 17.29%. ROE measures net income relative to shareholders' equity. This is above the typical market range of roughly 12-15%.
What is Bioteque Corporation's market cap?
Bioteque Corporation has a market capitalization of $7.48B.
Does 4107.TWO pay a dividend?
Yes. Bioteque Corporation currently yields 5.07%. Yield moves with the share price, so it changes daily even when the payment does not.
How much debt does 4107.TWO carry?
Bioteque Corporation has a debt-to-equity ratio of 0.14. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.
What is 4107.TWO's profit margin?
Bioteque Corporation reports a net profit margin of 26.54% — the share of revenue left after every cost, including tax and interest.
What sector is 4107.TWO in?
Bioteque Corporation is classified under Healthcare, in the Medical Instruments & Supplies industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.
Which exchange is 4107.TWO listed on?
Bioteque Corporation trades on TWO under the ticker 4107.TWO.
What is 4107.TWO's 52-week range?
Over the last year Bioteque Corporation has traded between $107.50 and $132.00.
Related Healthcare Stocks
Popular Stocks
Screens 4107.TWO currently matches
On the figures above, Bioteque Corporation passes the filters for 20 of our ready-made screens, among them Undervalued Dividend Stocks, High Dividend Stocks, Dividend Stocks. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.